SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Therapeutics (CTIC)
CTIC 9.0900.0%Jun 26 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (587)3/10/2005 1:13:05 AM
From: tuck  Read Replies (1) of 946
 
Thanks for the reminder. 175 PS2 patients out 850. Better odds, perhaps, and one would think with 850 patients that power will not be an issue. This might bolster my case for Stellar 2 having better chances than Stellar 3. Then again, maybe it doesn't. They might prove superiority, but not by a wide enough margin. They were gunning for a 30% difference in survival in Stellar 3, weren't they? Is that the case in these other two?

Anyhow, Miljenko's call is looking pretty good after all.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News